Your session is about to expire
← Back to Search
Herbal Extract
Gel capsule for Attention Deficit Disorder
N/A
Waitlist Available
Led By Dawn Beckman, MD
Research Sponsored by PepsiCo Global R&D
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo
Awards & highlights
Study Summary
This trial is assessing the effects of guayusa on alertness and mental fatigue compared to a placebo, using the COMPASS cognitive task, CDB, and mood, motivation, and energy measures.
Eligible Conditions
- Attention Deficit Disorder
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~change from pre-dose baseline to 60 minutes and 120 minutes post-guayusa consumption compared to placebo
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Other outcome measures
Cognitive Testing
Cognitive memory test: Words
Cognitive test RVIP
+5 moreTrial Design
3Treatment groups
Experimental Treatment
Placebo Group
Group I: Active capsule 2: Higher dose guayusa ingredientExperimental Treatment1 Intervention
Oral administration of 300 mg guayusa extract providing 60 mg caffeine
Group II: Active capsule 1: Lower dose guayusa ingredientExperimental Treatment1 Intervention
Oral administration of 175 mg guayusa extract providing 35 mg caffeine
Group III: Placebo capsulePlacebo Group1 Intervention
Oral administration of 0 mg guayusa extract, 0 mg caffeine. Capsule color-matched to actives 1 and 2 to disguise potential differences in color of contents.
Find a Location
Who is running the clinical trial?
PepsiCo Global R&DLead Sponsor
89 Previous Clinical Trials
12,601 Total Patients Enrolled
Dawn Beckman, MDPrincipal InvestigatorMérieux NutriSciences
8 Previous Clinical Trials
425 Total Patients Enrolled
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger